Approval · Notice of Compliance 1830 · 1999
RAXAR: Notice of Compliance 1830
Issued August 25, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1830
- Date
- August 25, 1999
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strengths
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAXAR | 02240720 | — |
| RAXAR | 02240721 | — |
Medicinal ingredients
- GREPAFLOXACIN HYDROCHLORIDE 400 MG per TAB
- GREPAFLOXACIN HYDROCHLORIDE 600 MG per TAB